Literature DB >> 33939799

Retrospective Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Symptomatic Patients Prior to Widespread Diagnostic Testing in Southern California.

Evann E Hilt1, James Boocock2,3,4, Marisol Trejo1, Catherine Q Le1, Longhua Guo2,3,4, Yi Zhang2, Laila Sathe1, Valerie A Arboleda1,2, Yi Yin2, Joshua S Bloom2,3, Pin-Chieh Wang5, Joann G Elmore5, Leonid Kruglyak2,3,4, Lasata Shrestha6, Shah A Mohamed Bakhash6, Michelle Lin6, Hong Xie6, Meei-Li Huang6, Pavitra Roychoudhury6, Alexander Greninger6, Sukantha Chandrasekaran1, Shangxin Yang1, Omai B Garner1.   

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused one of the worst pandemics in recent history. Few reports have revealed that SARS-CoV-2 was spreading in the United States as early as the end of January. In this study, we aimed to determine if SARS-CoV-2 had been circulating in the Los Angeles (LA) area at a time when access to diagnostic testing for coronavirus disease 2019 (COVID-19) was severely limited.
METHODS: We used a pooling strategy to look for SARS-CoV-2 in remnant respiratory samples submitted for regular respiratory pathogen testing from symptomatic patients from November 2019 to early March 2020. We then performed sequencing on the positive samples.
RESULTS: We detected SARS-CoV-2 in 7 specimens from 6 patients, dating back to mid-January. The earliest positive patient, with a sample collected on January 13, 2020 had no relevant travel history but did have a sibling with similar symptoms. Sequencing of these SARS-CoV-2 genomes revealed that the virus was introduced into the LA area from both domestic and international sources as early as January.
CONCLUSIONS: We present strong evidence of community spread of SARS-CoV-2 in the LA area well before widespread diagnostic testing was being performed in early 2020. These genomic data demonstrate that SARS-CoV-2 was being introduced into Los Angeles County from both international and domestic sources in January 2020.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; diagnostic testing

Mesh:

Year:  2022        PMID: 33939799      PMCID: PMC8135745          DOI: 10.1093/cid/ciab360

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020.

Authors:  Trevor A Crowell; Ibrahim I Daud; Jonah Maswai; John Owuoth; Valentine Sing'oei; Michelle Imbach; Nicole Dear; Fred Sawe; Leigh Anne Eller; Christina S Polyak; Julie A Ake
Journal:  AIDS       Date:  2021-11-15       Impact factor: 4.177

2.  Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes.

Authors:  Lasata Shrestha; Michelle J Lin; Hong Xie; Margaret G Mills; Shah A Mohamed Bakhash; Vinod P Gaur; Robert J Livingston; Jared Castor; Emily A Bruce; Jason W Botten; Meei-Li Huang; Keith R Jerome; Alexander L Greninger; Pavitra Roychoudhury
Journal:  J Mol Diagn       Date:  2022-07-18       Impact factor: 5.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.